Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antaitasvir phosphate + yiqibuvir in adult chronic hepatitis C (genotypes 1-6)
CTR20211194Phase 3Completed
- Sponsor
- Guangdong Dongyangguang Pharmaceutical
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of antaitavir hasophate, encofosbuvir in hepatitis C virus infection, sponsored by Guangdong Dongyangguang Pharmaceutical. Started Jun 2021; status: completed.
02
Drugs
antaitavir hasophateencofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20211194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211194.